Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hirosato
Hirosato Amano, Shizuoka JP
| Patent application number | Description | Published |
|---|---|---|
| 20090129838 | PARTICLE SUPPLY APPARATUS AND IMAGING APPARATUS - A particle supply apparatus is disclosed that includes a particle accommodating unit that accommodates particles, a gas spouting unit that is arranged at a bottom portion of the particle accommodating unit and is configured to spout gas toward the particles, a conveying mechanism that applies suction to the particles accommodated in the particle accommodating unit and conveys the particles toward a supply destination, and a gas discharge unit that discharges gas contained within the particle accommodating unit toward an exterior side of the particle accommodating unit. | 05-21-2009 |
Hirosato Ebiike, Kanagawa JP
| Patent application number | Description | Published |
|---|---|---|
| 20100069629 | PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF - A drug is provided that is useful as a preventive or therapeutic for cancer as a result of having superior PI3K inhibitory effects as well as superior stability in the body and water-solubility. | 03-18-2010 |
| 20100168430 | MULTIKINASE INHIBITOR - It is intended to provide a compound represented by the formula (1): | 07-01-2010 |
| 20100324284 | PYRROLOPYRIMIDINE DERIVATIVE AS P13K INHIBITOR AND USE THEREOF - A preventive or therapeutic agent of a proliferative disease such as cancer, having superior PI3K inhibitory effects, superior cell proliferation inhibitory action as well as superior stability in a body and water solubility, is provided. | 12-23-2010 |
Hirosato Fujii, Shizuoka JP
| Patent application number | Description | Published |
|---|---|---|
| 20090111777 | Jelly Composition - It is intended to provide a composition having at least one effect among the following effects; a plurality of medicinal ingredients can be taken as one preparation and the convenience for patients is excellent; the drug compliance is excellent; the amount of jelly composition to be taken at a time is small; the release of an active ingredient in the digestive tract is excellent; the absorption of an active ingredient to the body is excellent; the storage stability of an active ingredient is excellent; the dispersibility of an active ingredient in the composition is excellent; the storage stability of the composition is excellent; the syneresis of the composition is less, it has an appropriate jelly strength to a degree that does not disintegrate during carrying and before taking and easily disintegrates after taking; the handleability during preparation of the composition is excellent; the portability of the composition is excellent; the feeling of taking the composition is excellent; it has an effect on reducing side effects; and the like. The jelly composition contains a polyvalent unsaturated fatty acid, a second medicinal ingredient, an emulsifying agent and a gelling agent. | 04-30-2009 |